Congenital chylothorax: current perspectives and trends

References

• Al-Tawil K, Ahmed G, Al-Hathal M, Al-Jarallah Y, Campbell N. Congenital chylothorax. Am J Perinatol. 2000;17(3):121–126.
   Web of Science ®Google Scholar
• De Beer HG, Mol MJ, Janssen JP. Chylothorax. Neth J Med. 2000;56(1):25–31.
   Web of Science ®Google Scholar
• Dendale J, Comet P, Amram D, et al. Le chylothorax de découverte anténatale. [Prenatal diagnosis of chylothorax]. Arch Pediatr. 1999;6(8):867–871. French.
   Google Scholar
• Dubin PJ, King IN, Gallagher PG. Congenital chylothorax. Curr Opin Pediatr. 2000;12(5):505–509.
   Web of Science ®Google Scholar
• Van Straaten HL, Gerards LJ, Krediet TG. Chylothorax in the neonatal period. Eur J Pediatr. 1993;152(1):2–5.
   Web of Science ®Google Scholar
• Rocha G. Pleural effusions in the neonate. Curr Opin Pulm Med. 2007;13(4):305–311.
   Web of Science ®Google Scholar
• Van Aerde J, Campbell AN, Smyth JA, Lloyd D, Bryan MH. Spontaneous chylothorax in newborns. Am J Dis Child. 1984;138(10):961–964.
   Google Scholar
• Downie L, Sasi A, Malhotra A. Congenital chylothorax: associations and neonatal outcomes. J Paediatr Child Health. 2014;50(3):234–238.
   Web of Science ®Google Scholar
• Attar M, Donn S. Congenital chylothorax. Semin Fetal Neonatal Med. 2017;22(4):234–239.
   PubMed Web of Science ®Google Scholar
• Smets K. X-linked myotubular myopathy and chylothorax. Neuromuscul Disord. 2008;18(2):183–184.
   Web of Science ®Google Scholar
• Huang XZ, Wu JF, Ferrando R, et al. Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol Cell Biol. 2000;20(14):5208–5215.
   PubMed Web of Science ®Google Scholar
• Ma GC, Liu CS, Chang SP, et al. A recurrent ITGA9 missense mutation in human fetuses with severe chylothorax: possible correlation with poor response to fetal therapy. Prenat Diagn. 2008;28(11):1057–1063.
   Web of Science ®Google Scholar
• Brodszki N, Lansberg JK, Dictor M, et al. A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr. 2011;100(11):1448–1453.
   Web of Science ®Google Scholar
• Tutor JD. Chylothorax in infants and children. Pediatrics. 2014;133(4):722–733.
   PubMed Web of Science ®Google Scholar
• Soto-Martinez M, Massie J. Chylothorax: diagnosis and management in children. Paediatr Respir Rev. 2009;10(4):199–207.
   Web of Science ®Google Scholar
• Chan SY, Lau W, Wong WH, Cheng LC, Chau AK, Cheung YF. Chylothorax in children after congenital heart surgery. Ann Thorac Surg. 2006;82(5):1650–1656.
   Web of Science ®Google Scholar
• Healy F, Hanna BD, Zinman R. Pulmonary complications of congenital heart disease. Paediatr Respir Rev. 2012;13(1):10–15.
   Web of Science ®Google Scholar
• Milonakis M, Chatzis AC, Giannopoulos NM, et al. Etiology and management of chylothorax following pediatric heart surgery. J Card Surg. 2009;24(4):369–373.
   Web of Science ®Google Scholar
• Chun K, Colombani PM, Dudgeon DL, Haller JA Jr. Diagnosis and management of congenital vascular rings: a 22-year experience. Ann Thorac Surg. 1992;53(4):597–602. discussion 602–603.
   Web of Science ®Google Scholar
• Naik S, Greenough A, Zhang YX, Davenport M. Prediction of morbidity during infancy after repair of congenital diaphragmatic hernia. J Pediatr Surg. 1996;31(12):1651–1654.
   Web of Science ®Google Scholar
• Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C. Etiology and management of pediatric chylothorax. J Pediatr. 2000;136(5):653–658.
   Web of Science ®Google Scholar
• Mosby-Year Book Inc. Mosby’s Medical, Nursing and Allied Health Dictionary. Fourth ed. Maryland Heights, MO: Mosby-Year Book Inc; 1994:335.
   Google Scholar
• Williams KR, Burford TH. The management of chylothorax. Ann Surg. 1964;160:131–140.
   Web of Science ®Google Scholar
• Teba L, Dedhia HV, Bowen R, Alexander JC. Chylothorax review. Crit Care Med. 1985;13(1):49–52.
   Web of Science ®Google Scholar
• Ferguson M, Shahinian H, Michelassi F. Lymphatic smooth muscle responses to leukotrienes, histamine, and platelet activating factor. J Surg Res. 1988;44(2):172–177.
   Web of Science ®Google Scholar
• Marieb E, Hoehn K. Human Anatomy & Physiology. 8 ed. San Francisco, CA: Benjamin and Cummings; 2010.
   Google Scholar
• Kindt T, Goldsby R, Osborne B, et al. Kuby Immunology. New York: W.H. Freeman; 2007.
   Google Scholar
• Bellini C, Hennekam R. Non-immune hydrops fetalis: a short review of etiology and pathophysiology. Am J Med Genet A. 2012;158A(3):597–605.
   PubMed Web of Science ®Google Scholar
• De Hann TR, Oepkes D, Beersma MF, et al. Aetiology, diagnosis and treatment of hydrops foetalis. Curr Pediatr Rev. 2005;1:63–72.
   Google Scholar
• Ayida GA, Soothil PW, Rodeck CH. Survival in non-immune hydrops fetalis without malformation of chromosomal abnormalities after invasive treatment. Fetal Diagn Ther. 1995;10:101–105.
   PubMed Web of Science ®Google Scholar
• Huang HR, Tsay PK, Chiang MC, Lien R, Chou YH. Prognostic factors and clinical features in liveborn neonates with hydrops fetalis. Am J Perinatol. 2007;24:33–38.
   PubMed Web of Science ®Google Scholar
• Prasad C, Rupar CA. Non-immune hydrops: genetic and metabolic causes. Perinatology. 2006;8:164–174.
   Google Scholar
• Jones DC. Nonimmune fetal hydrops: diagnosis and obstetrical management. Semin Perinatol. 1995;19:447–461.
   PubMed Web of Science ®Google Scholar
• Fahnenstich H, Schmid G, Haverkamp F, et al. Non-immune hydrops fetalis—an analysis of liveborn cases. Pediatr Rev Commun. 1992;6:231–241.
   Google Scholar
• Lee CJ, Tsao PN, Chen CY, Hsieh WS, Liou JY, Chou HC. Prenatal therapy improves the survival of premature infants with congenital chylothorax. Pediatr Neonatol. 2016;57(2):127–132.
   Web of Science ®Google Scholar
• Chen CP. Fetal therapy and cytogenetic testing: prenatal detection of chromosome aberration during thoracocentesis for congenital chylothorax by karyotyping from pleural effusion fluid and review of the literature. Genet Couns. 2005;16(3):301–305.
   Google Scholar
• Bartha JL, Comino-Delgado R. Fetal chylothorax response to maternal dietary treatment. Obstet Gynecol. 2001;97(5 pt 2):820–823.
   Web of Science ®Google Scholar
• Chen C, Chang T, Wang W. Resolution of fetal bilateral chylothorax and ascites after two unilateral thoracocenteses. Ultrasound Obstet Gynecol. 2001;18:401–406.
   Web of Science ®Google Scholar
• Picone O, Benachi A, Mandelbrot L, Ruano R, Dumez Y, Dommergues M. Thoracoamniotic shunting for fetal pleural effusions with hydrops. Am J Obstet Gynecol. 2004;191(6):2047–2050.
   Web of Science ®Google Scholar
• Okawa T, Takano Y, Fujimori K, Yanagida K, Sato A. A new fetal therapy for chylothorax: pleurodesis with OK-432. Ultrasound Obstet Gynecol. 2001;18(4):376–377.
   Web of Science ®Google Scholar
• Tanemura M, Nishikawa N, Kojima K, Suzuki Y, Suzumori K. A case of successful fetal therapy for congenital chylothorax by intrapleural injection of OK-432. Ultrasound Obstet Gynecol. 2001;18(4):371–375.
   Web of Science ®Google Scholar
• Jorgensen C, Brocks V, Bang J, Jorgensen FS, Rønsbro L. Treatment of severe fetal chylothorax associated with pronounced hydrops with intrapleural injection of OK-432. Ultrasound Obstet Gynecol. 2003;21(1):66–69.
   Web of Science ®Google Scholar
• Tsukihara A, Tanemura M, Suzuki Y, Sato T, Tanaka T, Suzumori K. Reduction of pleural effusion by OK-432 in a fetus complicated with congenital hydrothorax. Fetal Diagn Ther. 2004;19(4):327–331.
   Web of Science ®Google Scholar
• Chen M, Chen CP, Shih JC, et al. Antenatal treatment of chylothorax and cystic hygroma with OK-432 in nonimmune hydrops fetalis. Fetal Diagn Ther. 2005;20(4):309–315.
   PubMed Web of Science ®Google Scholar
• Reece E, Goldstein I, Hobbins J. Fundamentals of Obstetric and Gynecologic Ultrasound. Stamford,CT. Appleton and Lange; 1994.
   Google Scholar
• Watson WJ, Munson DP, Christensen MW. Bilateral fetal chylothorax: results of unilateral in utero therapy. Am J Perinatol. 1996;13(2):115–117.
   Web of Science ®Google Scholar
• Rodeck CH, Fisk NM, Fraser DI, et al. Long-term in utero drainage of fetal hydrothorax. N Engl J Med. 1988;319(17):1135–1138.
   Web of Science ®Google Scholar
• Smith RP, Illanes S, Denbow ML, et al. Outcome of fetal pleural effusions treated by thoracoamniotic shunting. Ultrasound Obstet Gynecol. 2005;26(1):63–66.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Azar GB. Thoraco-amniotic shunting. Fetal Diagn Ther. 1990;5(3–4):153–164.
   PubMedGoogle Scholar
• Thompson PJ, Greenough A, Nicolaides KH. Respiratory function in infancy following pleuro-amniotic shunting. Fetal Diagn Ther. 1993;8(2):79–83.
   Web of Science ®Google Scholar
• Wilson RD, Baxter JK, Johnson MP, et al. Thoracoamniotic shunts: fetal treatment of pleural effusions and congenital cystic adenomatoid malformations. Fetal Diagn Ther. 2004;19(5):413–420.
   PubMed Web of Science ®Google Scholar
• Mussat P, Dommergues M, Parat S, et al. Congenital chylothorax with hydrops: postnatal care and outcome following antenatal diagnosis. Acta Paediatr. 1995;84(7):749–755.
   Web of Science ®Google Scholar
• Mallmann M, Graham V, Rosing B, et al. Thoracoamniotic shunting for fetal hydrothorax: predictors of intrauterine course and postnatal outcome. Fetal Diagn Ther. 2017;41:58–65.
   Web of Science ®Google Scholar
• Sepulveda W, Galindo A, Sosa A, Diaz L, Flores X, de la Fuente P. Intrathoracic dislodgement of pleuro-amniotic shunt. Three case reports with long-term follow-up. Fetal Diagn Ther. 2005; 20(2):102–105.
   Web of Science ®Google Scholar
• Samuel M, McCarthy L, Boddy SA. Efficacy and safety of OK-432 sclerotherapy for giant cystic hygroma in a newborn. Fetal Diagn Ther. 2000;15(2):93–96.
   Web of Science ®Google Scholar
• Levine C. Primary disorders of the lymphatic vessels – a unified concept. J Pediatr Surg. 1989;24(3):233–240.
   Web of Science ®Google Scholar
• Young S, Dalgleish S, Eccleston A, Akierman A, McMillan D. Severe congenital chylothorax treated with octreotide. J Perinatol. 2004;24(3):200–202.
   Google Scholar
• Lamberts SW, van der Lely AJ, de Herder WW, et al. Octreotide. N Engl J Med. 1996;334(4):246–254.
   PubMed Web of Science ®Google Scholar
• Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr. 1993;123(4):644–650.
   Web of Science ®Google Scholar
• Rasiah SV, Oei J, Lui K. Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health. 2004;40(9–10):585–588.
   Web of Science ®Google Scholar
• Das A, Shah P. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev. 2010;(9):CD006388.
   Web of Science ®Google Scholar
• Mohseni-Bod H, Macrae D, Slavik Z. Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe? Pediatr Crit Care Med. 2004;5(4):356–357.
   Google Scholar
• Reck-Burneo CA, Parekh A, Velcek FT. Is octreotide a risk factor in necrotizing enterocolitis? J Pediatr Surg. 2008;43(6):1209–1210.
   Web of Science ®Google Scholar
• Arevalo RP, Bullabh P, Krauss AN, Auld PA, Spigland N. Octreotide-induced hypoxemia and pulmonary hypertension in premature neonates. J Pediatr Surg. 2003;38(2):251–253.
   Web of Science ®Google Scholar
• Malleske DT, Yoder BA. Congenital chylothorax treated with oral sildenafil: a case report and review of the literature. J Perinatol. 2015;35(5):384–386.
   Web of Science ®Google Scholar
• Kajiya K, Huggenberger R, Drinnenberg I, Ma B, Detmar M. Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation. FASEB J. 2008;22(2):530–537.
   Web of Science ®Google Scholar
• Jeon Y, Heo Y, Kim C, et al. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell Mol Life Sci. 2005;62(11):1198–1220.
   PubMed Web of Science ®Google Scholar
• Hammill AM, Wentzel M, Gupta A, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57(6):1018–1024.
   PubMed Web of Science ®Google Scholar
• McCormick A, Rosenberg S, Trier K, et al. A case of a central conducting lymphatic anomaly responsive to sirolimus. Pediatrics. 2016;137(1).
   Web of Science ®Google Scholar
• Mizuno T, Fukuda T, Emoto C, et al. Developmental pharmacokinetics of sirolimus: implications for precision dosing in neonates and infants with complicated vascular anomalies. Pediatr Blood Cancer. Epub 2017 Feb 16;64(8).
   Web of Science ®Google Scholar
• Gupta V, Mahendri NV, Tete P, Santhanam S. Skimmed milk preparation in management of congenital chylothorax. Indian Pediatr. 2014;51(2):146–148.
   Web of Science ®Google Scholar
• Lopez G. Use of fortified skimmed breast milk to feed infants with postoperative chylothorax. Scholar Arch. 2015:3658.
   Google Scholar
• Cohan RH, Saeed M, Schwab SJ, Perlmutt LM, Dunnick NR. Povidone-iodine sclerosis of pelvic lymphoceles: a prospective study. Urol Radiol. 1988;10(4):203–206.
   Google Scholar
• Aubard Y, Derouineau I, Aubard V, Chalifour V, Preux PM. Primary fetal hydrothorax: a literature review and proposed antenatal clinical strategy. Fetal Diagn Ther. 1998;13:325–333.
   PubMed Web of Science ®Google Scholar
• Engum SA, Rescorla FJ, West KW, Scherer LR 3rd, Grosfeld JL. The use of pleuroperitoneal shunts in the management of persistent chylothorax in infants. J Pediatr Surg. 1999;34(2):286–290.
   Web of Science ®Google Scholar
• Buttiker V, Fanconi S, Burger R. Chylothorax in children: guidelines for diagnosis and management. Chest. 1999;116(3):682–687.
   Web of Science ®Google Scholar
• Hargus EP, Carson SD, McGrath RL, Wolfe RR, Clarke DR. Chylothorax and chylopericardial tamponade following Blalock-Taussig anastomosis. J Thorac Cardiovasc Surg. 1978;75(4):642–645.
   Web of Science ®Google Scholar
• Murphy MC, Newman BM, Rodgers BM. Pleuroperitoneal shunts in the management of persistent chylothorax. Ann Thorac Surg. 1989;48(2):195–200.
   Web of Science ®Google Scholar
• Stringel G, Mercer S, Bass J. Surgical management of persistent postoperative chylothorax in children. Can J Surg. 1984;27(6):543–546.
   Web of Science ®Google Scholar
• Soto-Martinez ME, Clifford V, Clarnette T, Ranganathan S, Massie RJ. Spontaneous chylothorax in a 2-year-old child. Med J Aust. 2009;190(5):262–264.
   Web of Science ®Google Scholar
• Aoki M, Kato F, Saito H, et al. Successful treatment of chylothorax by bleomycin for Gorham’s disease. Clin Orthop Relat Res. 1996;(330):193–197.
   Web of Science ®Google Scholar
• Brissaud O, Desfrere L, Mohsen R, et al. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed. 2003;88(6):F531–F533.
   Web of Science ®Google Scholar
• Stenzl W, Rigler B, Tscheliessnigg KH, Beitzke A, Metzler H. Treatment of postsurgical chylothorax with fibrin glue. Thorac Cardiovasc Surg. 1983;13(1):35–36.
   Google Scholar
• Scottoni F, Fusaro F, Conforti A, Morini F, Bagolan P. Pleurodesis with povidone-iodine for refractory chylothorax in newborns: personal experience and literature review. J Pediatr Surg. 2015;50(10):1722–1725.
   Web of Science ®Google Scholar
• Ancona A, Suarez de la TR, Macotela E. Allergic contact dermatitis from povidone-iodine. Contact Dermatitis. 1985;13(2):66–68.
   Web of Science ®Google Scholar
• Mitanchez D, Walter-Nicolet E, Salomon R, et al. Congenital chylothorax: what is the best strategy? Arch Dis Child Fetal Neonatal Ed. 2006;91(2):F153–F154.
   Web of Science ®Google Scholar
• Okazaki T, Iwatani S, Yanai T, et al. Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg. 2007;42(2):386–389.
   Web of Science ®Google Scholar
• Katanyuwong P, Dearani J, Driscoll D. The role of pleurodesis in the management of chylous pleural effusion after surgery for congenital heart disease. Pediatr Cardiol. 2009;30(8):1112–1116.
   Web of Science ®Google Scholar
• Kim JE, Lee C, Park KI, Park MS, Namgung R, Park IK. Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion. Korean J Pediatr. 2012;55(5):177–180.
   Google Scholar
• Matsukuma E, Aoki Y, Sakai M, et al. Treatment with OK-432 for persistent congenital chylothorax in newborn infants resistant to octreotide. J Pediatr Surg. 2009;44(3):e37–e39.
   Google Scholar
• Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg. 1994;29(6):784–785.
   Web of Science ®Google Scholar
• Utture A, Kodur V, Mondkar J. Chemical Pleurodesis with Oxytetracycline in Congenital Chylothorax. Indian pediatrics. 2016;53(12):1105–1106.
   Web of Science ®Google Scholar
• Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120(1):56–64.
   PubMed Web of Science ®Google Scholar
• Antony VB, Rothfuss KJ, Godbey SW, Sparks JA, Hott JW. Mechanism of tetracycline-hydrochloride-induced pleurodesis. Tetracycline-hydrochloride-stimulated mesothelial cells produce a growth-factor-like activity for fibroblasts. Am Rev Respir Dis. 1992;146(4):1009–1013.
   Google Scholar
• Hodges MM, Crombleholme TM, Meyers M, et al. Massive fetal chylothorax successfully treated with postnatal talc pleurodesis: a case report and review of the literature. J Pediatr Surg Case Rep. 2016;9(suppl C):1–4.
   Google Scholar
• Nadolski GJ, Itkin M. Thoracic duct embolization for nontraumatic chylous effusion: experience in 34 patients. Chest. 2013;143(1):158–163.
   Web of Science ®Google Scholar
• Itkin M, Krishnamurthy G, Naim MY, Bird GL, Keller MS. Percutaneous thoracic duct embolization as a treatment for intrathoracic chyle leaks in infants. Pediatrics. 2011;128(1):e237–e241.
   Web of Science ®Google Scholar
• Dori Y. Novel lymphatic imaging techniques. Tech Vasc Interv Radiol. 2016;19(4):255–261.
   Google Scholar
• Bellini C, Boccardo F, Campisi C. Lymphatic dysplasias in newborns and children: role of lymphoscintigraphy. J Pediatr. 2008;152(4):587–589.
   Web of Science ®Google Scholar
• Bernet-Buettiker V, Waldvogel K, Cannizzaro V, Albisetti M. Antithrombin activity in children with chylothorax. Eur J Cardiothorac Surg. 2006;29:406–409.
   Web of Science ®Google Scholar
• Wasmuth-Pietzuch A, Hansmann M, Bartmann P, Heep A. Congenital chylothorax: lymphopenia and high risk of neonatal infections. Acta Paediatr. 2004;93(2):220–224.
   Web of Science ®Google Scholar
• Garty BZ, Levinson AI, Danon YL, Wilmott R, Douglas SD. Lymphocyte subpopulations in children with abnormal lymphatic circulation. J Allergy Clin Immunol. 1989;84:515–520.
   Web of Science ®Google Scholar
• Orange J, Geha R, Bonilla F. Acute chylothorax in children: selective retention of memory T cells and natural killer cells. J Pediatr. 2003;143:243–249.
   Web of Science ®Google Scholar
• Earth’s Lab. Thoracic duct, Dr Joseph H Volker. [webpage on the Internet].Available from https://earthslab.com/anatomy/thoracic-duct-formation-course-connection-tributaries-and-development/. Accessed December 4, 2017.
   Google Scholar